Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Market Cap ($1.65 Billion)
Market Cap & Net Worth: Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357)
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd market cap. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (SHE:300357) has a market capitalization of $1.65 Billion (CN¥11.28 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #6614 globally and #1282 in its home market, demonstrating a 11.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's stock price CN¥21.54 by its total outstanding shares 523584000 (523.58 Million). Also see 300357 cash flow conversion for how efficiently the company converts equity into cash flow.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Market Cap History (2015–2026)
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows growth from $1.13 Billion to $1.65 Billion (6.05% CAGR). Check Zhejiang Wolwo Bio-Pharmaceutical Co Ltd share price for real-time trading data and today's change.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300357 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.68x
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's market cap is 1.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.90x
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's market cap is 4.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.13 Billion | $267.11 Million | $117.82 Million | 4.24x | 9.60x |
| 2016 | $789.86 Million | $312.09 Million | $129.20 Million | 2.53x | 6.11x |
| 2017 | $1.12 Billion | $385.58 Million | $186.10 Million | 2.90x | 6.00x |
| 2018 | $1.52 Billion | $500.74 Million | $232.88 Million | 3.04x | 6.53x |
| 2019 | $3.30 Billion | $639.35 Million | $298.30 Million | 5.16x | 11.06x |
| 2020 | $5.75 Billion | $636.21 Million | $278.45 Million | 9.03x | 20.64x |
| 2021 | $4.30 Billion | $807.69 Million | $337.99 Million | 5.33x | 12.73x |
| 2022 | $4.16 Billion | $896.02 Million | $348.77 Million | 4.64x | 11.92x |
| 2023 | $2.20 Billion | $848.19 Million | $310.18 Million | 2.59x | 7.10x |
| 2024 | $1.56 Billion | $925.39 Million | $317.82 Million | 1.68x | 4.90x |
Competitor Companies of 300357 by Market Capitalization
Companies near Zhejiang Wolwo Bio-Pharmaceutical Co Ltd in the global market cap rankings as of November 4, 2026. Also see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd total assets for a full breakdown of the balance sheet.
Key companies related to Zhejiang Wolwo Bio-Pharmaceutical Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #20 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #42 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1410.99 |
| #20 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #29 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $270.56 |
| #42 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $288.84 |
Market Capitalization of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2015–2026)
Market capitalization of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's market cap moved from $1.13 Billion to $ 1.65 Billion, with a yearly change of 6.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.65 Billion | -24.02% |
| 2025 | CN¥2.17 Billion | +39.52% |
| 2024 | CN¥1.56 Billion | -29.27% |
| 2023 | CN¥2.20 Billion | -47.06% |
| 2022 | CN¥4.16 Billion | -3.40% |
| 2021 | CN¥4.30 Billion | -25.12% |
| 2020 | CN¥5.75 Billion | +74.28% |
| 2019 | CN¥3.30 Billion | +116.82% |
| 2018 | CN¥1.52 Billion | +36.18% |
| 2017 | CN¥1.12 Billion | +41.41% |
| 2016 | CN¥789.86 Million | -30.20% |
| 2015 | CN¥1.13 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.65 Billion USD |
| MoneyControl | $1.65 Billion USD |
| MarketWatch | $1.65 Billion USD |
| marketcap.company | $1.65 Billion USD |
| Reuters | $1.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnost… Read more